Medtronic (MDT) Curent Deferred Tax Liability (2014 - 2015)

Medtronic (MDT) posted Curent Deferred Tax Liability of $142.0 million for Q4 2015, up 18.33% sequentially from $120.0 million in Q3 2015.

Medtronic (MDT) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends

Medtronic has reported Curent Deferred Tax Liability for 2 years, with the latest figure at $142.0 million in Q4 2015.

Quarterly Curent Deferred Tax Liability changed N/A year-over-year to $142.0 million in Q4 2015, while the trailing twelve-month figure through Oct 2015 was $142.0 million (changed N/A YoY) and the FY2015 annual result came in at $119.0 million, up 526.32% from the prior year.
Curent Deferred Tax Liability advanced to $142.0 million in Q4 2015 per MDT's latest filing, from $120.0 million in the prior quarter.
Over five years, Curent Deferred Tax Liability peaked at $142.0 million in Q4 2015 and troughed at $19.0 million in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Curent Deferred Tax Liability (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn	-
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn	-
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	-
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn	-
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	-
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn	-
10	Zimmer Biomet Holdings	19.21 Bn	18.80 Bn	1.54 Bn	-

Download Data